GARIBOTTO, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 33.933
AS - Asia 3.993
NA - Nord America 2.136
SA - Sud America 340
AF - Africa 76
OC - Oceania 7
Totale 40.485
Nazione #
IT - Italia 33.166
US - Stati Uniti d'America 1.990
SG - Singapore 1.698
CN - Cina 1.083
VN - Vietnam 646
FR - Francia 297
BR - Brasile 211
BD - Bangladesh 156
FI - Finlandia 147
HK - Hong Kong 144
DE - Germania 93
AR - Argentina 59
MX - Messico 58
CA - Canada 53
GB - Regno Unito 50
JP - Giappone 48
CH - Svizzera 40
IQ - Iraq 31
NL - Olanda 31
IN - India 30
ID - Indonesia 27
IE - Irlanda 22
ZA - Sudafrica 19
PK - Pakistan 18
EC - Ecuador 16
CO - Colombia 14
RU - Federazione Russa 14
PH - Filippine 13
DZ - Algeria 12
ES - Italia 12
KR - Corea 12
PY - Paraguay 12
TH - Thailandia 12
PL - Polonia 11
JM - Giamaica 10
UA - Ucraina 10
EG - Egitto 8
KE - Kenya 8
MA - Marocco 8
TR - Turchia 8
AU - Australia 7
AZ - Azerbaigian 7
SA - Arabia Saudita 7
VE - Venezuela 7
CL - Cile 6
LB - Libano 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CZ - Repubblica Ceca 5
LT - Lituania 5
NP - Nepal 5
TW - Taiwan 5
UY - Uruguay 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
JO - Giordania 4
OM - Oman 4
PA - Panama 4
TN - Tunisia 4
UZ - Uzbekistan 4
BO - Bolivia 3
CR - Costa Rica 3
ET - Etiopia 3
IR - Iran 3
MY - Malesia 3
NG - Nigeria 3
SV - El Salvador 3
AO - Angola 2
AT - Austria 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BJ - Benin 2
CI - Costa d'Avorio 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SE - Svezia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AW - Aruba 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
GF - Guiana Francese 1
HN - Honduras 1
IL - Israele 1
Totale 40.479
Città #
Genova 18.468
Genoa 8.858
Rapallo 3.339
Vado Ligure 2.222
Singapore 838
San Jose 609
Lauterbourg 270
Ho Chi Minh City 192
Ashburn 188
Beijing 180
Helsinki 141
Hanoi 138
Hong Kong 138
New York 134
Council Bluffs 122
Bordighera 92
Santa Clara 84
Frankfurt am Main 77
Los Angeles 47
Tokyo 41
Zurich 38
Mexico City 36
Tianjin 33
Haiphong 31
Dallas 28
São Paulo 26
Orem 24
Da Nang 22
Rome 21
Biên Hòa 20
Boardman 20
Dublin 20
Chicago 17
Milan 17
Amsterdam 16
Baghdad 14
London 14
Toronto 14
Atlanta 12
Buffalo 12
Montreal 12
Phoenix 12
Shanghai 12
St Louis 12
Hải Dương 10
Asunción 9
Bắc Ninh 9
Cardiff 9
Columbus 9
Brooklyn 8
City of London 8
Guangzhou 8
Johannesburg 8
Ninh Bình 8
Rio de Janeiro 8
Warsaw 8
Chennai 7
Madrid 7
Nairobi 7
Bologna 6
Can Tho 6
Charlotte 6
Denver 6
Kingston 6
Lappeenranta 6
Memphis 6
Naples 6
Philadelphia 6
Phủ Lý 6
Quito 6
Quảng Ngãi 6
Rawalpindi 6
San Francisco 6
Bangkok 5
Basingstoke 5
Bogotá 5
Buenos Aires 5
Erbil 5
Jakarta 5
Las Vegas 5
Quận Ba 5
Salvador 5
Shenzhen 5
Verona 5
Amman 4
Baku 4
Beirut 4
Bình Dương 4
Cairo 4
Des Moines 4
Dhaka 4
Durban 4
Hangzhou 4
Houston 4
Kansas City 4
Karachi 4
Kyiv 4
Lima 4
Nuremberg 4
Osasco 4
Totale 36.987
Nome #
1,25-Dihydroxy vitamin D and coronary microvascular function 380
L'AMMONIOGENESI RENALE NELL'UOMO 333
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 330
Homocysteine exchange across skeletal muscle in patients with chronic kidney disease 315
APOPTOSIS AND MYOSTATIN mRNA ARE UPREGULATED IN THE SKELETAL MUSCLE OF PATIENTS WITH CHRONIC KIDNEY DISEASE 234
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 207
Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase 206
Interorgan handling of fibroblast growth factor-23 in humans 205
Soluble Toll-like Receptor 4: A New Player in Subclinical Inflammation and Malnutrition in Hemodialysis Patients 204
Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis. 203
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 203
Evaluation of Metabolic Acidosis in Patients With a Kidney Graft: Comparison of the Bicarbonate-Based and Strong Ion–Based Methods 199
Circadian monitoring of gastric juice mutagenicity. 199
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 198
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 197
Arteriovenous fistula of the native kidney: diagnosis by duplex Doppler ultrasound. 191
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients 190
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 187
Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss – a retrospective study 187
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 185
Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease 184
Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease 184
Postanaesthetic myoglobinuric renal failure: an isolated expression of malignant hyperthermia. 182
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 181
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease 180
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 180
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities 179
Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway 179
Early interstitial macrophage infiltration with mild dysfunction is associated with subsequent kidney graft loss 177
REPORT SUI DATI RACCOLTI DURANTE LA GIORNATA MONDIALE DEL RENE IN ITALIA NEGLI ANNI 2015-2016- Report for the World Kidney Days in Italy 2015-2016 177
Interorgan exchange of aminothiols in humans 175
Inter-organ leptin exchange in humans 174
Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells 172
The Organ Handling of Soluble Klotho in Humans 172
Peripheral tissue release of interleukin-6 in patients with chronic kidney diseases: Effects of end-stage renal disease and microinflammatory state 169
Abnormal amino acid metabolism after amino acid ingestion in chronic renal failure 169
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 167
Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria 165
Effects of Low-Protein, and Supplemented Very Low–Protein Diets, on Muscle Protein Turnover in Patients With CKD 165
Primary hyperoxaluria: a report of a case. 164
The control of muscle protein turnover in patients on peritoneal dialys 164
Amino acid loss with polyethersulfone. 163
Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: a long-term prospective cohort study. 163
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 163
Inter-organ amino acid exchange. 162
INDIVIDUAZIONE DEL RUOLO DELLA GLUTAMINASI FOSFATO-DIPENDENTE E DELLA GLUTAMINASI FOSFATO-INDIPENDENTE NELLA PRODUZIONE RENALE DI AMMONIACA 159
Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition 159
AMINO ACID METABOLISM AND THE LIVER IN RENAL FAILURE 158
Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure. 157
PROTEIN TURNOVER IN THE HUMAN KIDNEY 157
Amino acid imbalance in patients with chronic renal failure. 157
Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. 156
Low-protein diets for chronic kidney disease patients: the Italian experience 156
The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease 155
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy 155
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups 154
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 154
Gene expression in highly sensitized dialysis patients waiting for a kidney transplant: A real-time PCR analysis 154
Awareness of kidney diseases in general population and in high school students. Italian report for World Kidney Days 2010-2011 154
STUDY OF BIOASSAYABLE SOMATOMEDIN ON RENAL ARTERY AND VEIN 153
Mechanisms of renal ammonia production and protein turnover 153
Risk factors for kidney diseases and awareness of blood pressure and proteinuria in general population and in high school students: Italian report for World Kidney Days 2012-2013 152
Role of haematological, pulmonary and renal complications in the long-term prognosis of patients with lysinuric protein intolerance. 151
Myostatin: A Playmaker in Chronic Kidney Disease and Vascular Damage 151
Immunohistochemical Staining of TLR4 in Human Skeletal Muscle Samples 151
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. I. Studies in the postabsorptive state 149
Role of PKC-delta activity in glutathione-depleted neuroblastoma cells 148
Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis 147
Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk 147
Reversed-phase high-performance liquid chromatographic analysis of branched-chain keto acid hydrazone derivatives: optimization of techniques and application to branched-chain keto acid balance studies across the forearm. 146
Renal and extra-renal handling of glutathione in humans 146
EFFECTS OF CHRONIC RENAL INSUFFICIENCY AND METABOLIC ACIDOSIS ON GLUTAMINE METABOLISM IN MAN 146
Leptin as a uremic toxin interferes with neutrophil chemotaxis 146
Low protein diets and plant-based low protein diets: Do they meet protein requirements of patients with chronic kidney disease? 146
Phenylalanine hydroxylation across the kidney in humans 145
Apoptosis in the kidneys of patients with type 2 diabetic nephropathy. 145
SPLANCHNIC AMINO ACID AND PROTEIN TURNOVER IN HUMANS: INSIGHT FROM ISOTOPE DILUTION AND CATHETERIZATION STUDIES 144
Renal ammoniagenesis in man with chronic potassium depletion. 144
Kidney and splanchnic handling of Interleukin-6 in humans 144
Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism 144
Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons 144
Effects of microinflammation on growth hormone's sensitivity of potassium and amino acid metabolism in patients with chronic renal failure. 144
Renal ammoniagenesis in an early stage of metabolic acidosis in man 143
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 143
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients 143
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease 143
Muscle protein synthesis and degradation in hemodialysis (HD) patients with protein-energy malnutrition (PEM) 142
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 142
Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. 142
ALTERATA TRASMISSIONE INTRACELLULARE DI UN SEGNALE DEI FATTORI DI CRESCITA E STATO MICROINFIAMMATORIO SONO ASSOCIATI A DIFFERENTI EFFETTI CATABOLICI NEL MUSCOLO SCHELETRICO DEI PAZIENTI CON INSUFFICIENZA RENALE CRONICA 141
LONG-TERM RESPONSE OF RENAL FUNCTION IN CRESCENTIC MEMBRANOUS GLOMERULONEPHRITIS AFTER PLASMA EXCHANGE AND IMMUNOSUPPRESSIVE THERAPY 141
Apoptosis induced by serum withdrawal in human mesangial cells. Role of IGFBP-3 140
PULSE VERSUS DAILY ORAL CYCLOPHOSPHAMIDE FOR INDUCTION OF REMISSION IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: A RANDOMIZED TRIAL 140
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up 139
DETERMINANTS OF THE PARTITION OF RENAL AMMONIA PRODUCTION BETWEEN URINE AND VENOUS BLOOD IN MAN WITH METABOLIC ACID-BASE DISTURBANCES 139
Effects of chronic metabolic acidosis on splanchnic protein turnover and oxygen consumption in human beings 138
AMINO ACID BIOSYNTHESIS 138
[Activity of renal enzymes producing ammonia from glutamine in the absence of phosphate: 2. Effect of phosphate dependent glutaminase inhibition by heating]. 138
EFFECTS OF HEMODIALYSIS ON GUANIDINO-PROPIONIC ACID METABOLISM 138
Skeletal muscle protein synthesis and degradation in patients with chronic renal failure 137
Totale 16.961
Categoria #
all - tutte 131.815
article - articoli 108.044
book - libri 332
conference - conferenze 10.284
curatela - curatele 1.132
other - altro 1.264
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.759
Totale 263.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 0 0 203
2021/20223.767 102 320 239 399 181 270 205 857 150 333 231 480
2022/20233.966 372 210 46 384 610 725 16 329 752 58 388 76
2023/20242.038 88 280 42 221 151 392 124 162 135 41 157 245
2024/20255.908 147 423 172 412 736 550 494 894 232 305 617 926
2025/202610.238 1.187 244 620 914 1.432 1.015 1.806 551 738 1.037 563 131
Totale 41.010